Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| 1 |
NVIDIA
NVDA
|
+$1.06B |
| 2 |
Apple
AAPL
|
+$625M |
| 3 |
UnitedHealth
UNH
|
+$201M |
| 4 |
Cisco
CSCO
|
+$192M |
| 5 |
Johnson & Johnson
JNJ
|
+$182M |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
+$608M |
| 2 |
Broadcom
AVGO
|
+$240M |
| 3 |
United Rentals
URI
|
+$212M |
| 4 |
CRH
CRH
|
+$200M |
| 5 |
Pfizer
PFE
|
+$174M |
Sector Composition
| 1 | Technology | 18.69% |
| 2 | Financials | 17.09% |
| 3 | Industrials | 13.01% |
| 4 | Consumer Discretionary | 11.1% |
| 5 | Healthcare | 10.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3026
ALX Oncology
ALXO
$57.3M
| $561K | ﹤0.01% |
50,341
-83,881
| -62% | -$935K |
|
|
API
3027
Agora
API
$332M
| $561K | ﹤0.01% |
223,434
+100,486
| +82% | +$252K |
|
|
OGI
3028
Organigram Holdings
OGI
$220M
| $552K | ﹤0.01% |
256,662
+24,332
| +10% | +$52.3K |
|
3029
TIM SA
TIMB
$10.1B
| $551K | ﹤0.01% |
31,016
+1,322
| +4% | +$23.5K |
|
|
CPAC
3030
Cementos Pacasmayo
CPAC
$571M
| $546K | ﹤0.01% |
89,309
| – | – |
|
3031
American Well
AMWL
$112M
| $543K | ﹤0.01% |
33,502
-19,956
| -37% | -$324K |
|
3032
Woori Financial
WF
$13.2B
| $540K | ﹤0.01% |
16,656
+593
| +4% | +$19.2K |
|
3033
Noodles & Co
NDLS
$31.1M
| $532K | ﹤0.01% |
278,374
-79,822
| -22% | -$152K |
|
|
LENZ
3034
LENZ Therapeutics
LENZ
$1.13B
| $526K | ﹤0.01% |
23,537
+7,038
| +43% | +$157K |
|
|
AHT
3035
Ashford Hospitality Trust
AHT
$36.7M
| $525K | ﹤0.01% |
38,309
-5,401
| -12% | -$74K |
|
3036
Verastem
VSTM
$652M
| $515K | ﹤0.01% |
43,653
+4,230
| +11% | +$49.9K |
|
3037
Globalstar
GSAT
$4.99B
| $513K | ﹤0.01% |
+23,246
| New | +$513K |
|
3038
Monte Rosa Therapeutics
GLUE
$297M
| $512K | ﹤0.01% |
72,675
+48,362
| +199% | +$341K |
|
3039
Nektar Therapeutics
NKTR
$879M
| $508K | ﹤0.01% |
36,251
-193
| -0.5% | -$2.7K |
|
3040
Century Casinos
CNTY
$79M
| $507K | ﹤0.01% |
160,416
-63,023
| -28% | -$199K |
|
3041
American Shared Hospital Services
AMS
$16.3M
| $505K | ﹤0.01% |
171,201
+5,145
| +3% | +$15.2K |
|
|
CERE
3042
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $505K | ﹤0.01% |
+11,945
| New | +$505K |
|
|
TSRI
3043
DELISTED
TSR Inc. New
TSRI
| $503K | ﹤0.01% |
63,543
+2,126
| +3% | +$16.8K |
|
3044
Sea Limited
SE
$113B
| $503K | ﹤0.01% |
9,368
+175
| +2% | +$9.4K |
|
3045
Biohaven
BHVN
$1.53B
| $501K | ﹤0.01% |
9,163
-4
| -0% | -$219 |
|
|
JOYY
3046
JOYY Inc. American Depositary Shares
JOYY
$3.25B
| $495K | ﹤0.01% |
16,113
-2,108
| -12% | -$64.8K |
|
3047
Comscore
SCOR
$31.8M
| $495K | ﹤0.01% |
32,144
+5,785
| +22% | +$89.1K |
|
3048
Evolus
EOLS
$487M
| $493K | ﹤0.01% |
35,183
-39,305
| -53% | -$550K |
|
3049
Rocky Mountain Chocolate Factory
RMCF
$11.4M
| $492K | ﹤0.01% |
135,838
+3,224
| +2% | +$11.7K |
|
3050
Lee Enterprises
LEE
$26.4M
| $483K | ﹤0.01% |
36,243
-8,474
| -19% | -$113K |
|